Certolizumab pegol in rheumatoid arthritis: Current update

Fechtenbaum, M, Md Yusof, MY and Emery, P (2014) Certolizumab pegol in rheumatoid arthritis: Current update. Expert Opinion on Biological Therapy, 14 (6). 841 - 850. ISSN 1471-2598



  • Fechtenbaum, M
  • Md Yusof, MY
  • Emery, P
Keywords: Anti-TNF; Biological therapy; Certolizumab; PEGylation; Rheumatoid arthritis
  • Published: June 2014
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Rheumatology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Aug 2015 15:45
Last Modified: 27 Oct 2015 01:35
Published Version: http://dx.doi.org/10.1517/14712598.2014.900043
Status: Published
Publisher: Informa Healthcare
Identification Number: https://doi.org/10.1517/14712598.2014.900043
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online